Abstract 5580: Comparative Study on the Antihypertensive Efficacy of Compound Reserpine and Triamterene Tablets versus Spironolactone Combined with Indapamide in True Resistant Hypertension

三氨甲苯 医学 螺内酯 利血平 氢氯噻嗪 吲达帕胺 药理学 血压 养生 泌尿科 氯沙利酮 利尿剂 交叉研究 不利影响 安慰剂 随机对照试验 动态血压 噻嗪 原发性高血压 内科学 临床试验 麻醉 联合疗法 室上性心律失常 药物治疗 回廊的 心脏病学 低钾血症 内分泌学
作者
Yuanyuan Yao,xin zhang,Xiangyu Yang,Shanshan Jia,Xianghao Zuo,Xiaoping Chen
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:154 (Suppl_1)
标识
DOI:10.1161/circ.154.suppl_1.5580
摘要

Background: Resistant hypertension (RH), defined as uncontrolled blood pressure (BP) despite three or more antihypertensive agents including a diuretic, is pathophysiologically driven by increased blood volume and sympathetic overactivity. Although mineralocorticoid receptor antagonists (MRAs) are recommended as effective add-on therapy, their clinical utility is frequently limited by hyperkalemia and endocrine-related adverse effects. Compound reserpine and triamterene tablets, a Chinese-developed quadruple single-pill combination (dihydralazine 12.5 mg, reserpine 0.1 mg, hydrochlorothiazide 12.5 mg, and triamterene 12.5 mg), concurrently attenuate sympathetic activity and reduce sodium-fluid retention, positioning it as a promising therapeutic alternative for RH. Methods: A randomized crossover clinical trial has been conducted to compare the efficacy and safety of compound reserpine and triamterene tablets treatment regimen (two tablets of olmesartan/amlodipine (20 mg/5 mg, OA) + one tablet of compound reserpine and triamterene tablets) with those of a standard regimen (two tablets of OA+ indapamide 2.5 mg+ spironolactone 20 mg) in patients with true RH. Patients were recruited and randomly assigned in a 1:1 ratio to 2 crossover groups. The two groups will receive different combination therapies for 6 weeks, and will then switch to the other combination therapy for 6 weeks, with a 4-week wash-out. The primary outcome was the difference in 24-hour mean systolic blood pressure (SBP) between the two regimens after 6 weeks of intervention. Results: Of the 32 patients with true RH enrolled, 28 completed follow-up (mean age 57.0±9.8 years, 64.3% male), with a baseline 24-hour ambulatory BP of 144.4/88.9 mmHg on 2 OA tablets/day. After 6 weeks, the difference in 24h SBP between the two regimens was -2.28 mmHg (95% CI: -7.12, 2.55, P =0.340), and the upper CI limit was below the margin of 3 mm Hg, confirming the non-inferiority of the compound reserpine and triamterene tablets treatment regimen to the standard regimen. Compared with standard regimen, the study regimen demonstrated numerically higher BP control rates, lower BP load, and reduced heart rate, though differences were not statistically significant (all adjusted P > 0.05). No serious adverse events occurred, and serum uric acid levels were significantly lower with the study regimen than with the standard regimen ( P = 0.041). Conclusion: The compound reserpine and triamterene tablets treatment regimen showed non-inferior antihypertensive efficacy versus standard therapy for true RH, with no obvious neuropsychiatric adverse reactions and milder impact on serum uric acid. Trial registration : Chinese Clinical Trial Registry ChiCTR2400081878. Registered on March 14, 2024. ( http://www.chictr.org.cn )

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿的应助被luoshiwen采纳,获得10
刚刚
tangerine完成签到,获得积分10
1秒前
忧虑的靖巧完成签到 ,获得积分0
1秒前
shengjiangtai完成签到 ,获得积分10
1秒前
victor1995888发布了新的文献求助10
2秒前
ZBH完成签到,获得积分10
3秒前
3秒前
要减肥的安柏完成签到 ,获得积分10
4秒前
5秒前
东风的应助被花花采纳,获得10
5秒前
李天王发布了新的文献求助10
5秒前
yy完成签到,获得积分10
6秒前
6秒前
6秒前
cdercder的应助被胡萝卜卜采纳,获得10
6秒前
6秒前
8秒前
LingYue发布了新的文献求助10
8秒前
勤劳的乐安完成签到,获得积分10
8秒前
8秒前
WYL发布了新的文献求助10
9秒前
李健的应助被雨季采纳,获得10
9秒前
9秒前
暴躁的店员完成签到 ,获得积分20
9秒前
SIMON发布了新的文献求助10
9秒前
FionaZhang发布了新的文献求助10
9秒前
10秒前
cdercder的应助被科研助理795采纳,获得10
11秒前
TomCat发布了新的文献求助10
11秒前
阿里卡多完成签到 ,获得积分10
12秒前
WYL发布了新的文献求助10
12秒前
WYL发布了新的文献求助10
12秒前
WYL发布了新的文献求助10
12秒前
yy发布了新的文献求助30
12秒前
桐桐的应助被xhsz1111采纳,获得10
12秒前
小赞发布了新的文献求助10
13秒前
13秒前
41651653发布了新的文献求助10
13秒前
k.o.发布了新的文献求助10
13秒前
wy发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193348
求助须知:如何正确求助?哪些是违规求助? 9579548
关于积分的说明 21866040
捐赠科研通 7792906
什么是DOI,文献DOI怎么找? 3437242
关于科研通互助平台的介绍 2560702
邀请新用户注册赠送积分活动 2484066